Relyvrio and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Relyvrio (sodium phenylbutyrate; taurursodiol), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Riluzole, and have Amyotrophic lateral sclerosis.

The phase IV clinical study analyzes which people have Stools - watery when taking Relyvrio. It is created by eHealthMe based on reports of 646 people who have side effects when taking Relyvrio from the FDA, and is updated regularly.

What is Relyvrio?

Relyvrio has active ingredients of sodium phenylbutyrate; taurursodiol. eHealthMe is studying from 646 Relyvrio users. Check the latest studies of Relyvrio.

What is Stools - watery?

Stools - watery is found to be associated with 4,687 drugs and 5,937 conditions by eHealthMe. Check the latest studies of Stools - watery.

On Apr, 18, 2026

646 people reported to have side effects when taking Relyvrio.
Among them, 131 people (20.28%) have Stools - watery.

Among these 131 people:

* Approximation only. Some reports may have incomplete information.

Do you take Relyvrio and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Relyvrio:

Relyvrio (646 reports)

Stools - watery treatments and more:

Stools - watery (756,290 reports)

How severe was Stools - watery and when was it recovered:

Stools - watery in Relyvrio

Expand to all the drugs that have ingredients of sodium phenylbutyrate; taurursodiol:

Stools - watery and drugs with ingredients of sodium phenylbutyrate; taurursodiol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relyvrio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,687 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,937 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sodium phenylbutyrate; taurursodiol (the active ingredients of Relyvrio) and Relyvrio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.